BRCNF Stock Chart & Stats
$1.19
-$0.07(-5.34%)
At close: 4:00 PM EDT
$1.19
-$0.07(-5.34%)
Day’s Range― - ―
52-Week Range$0.35 - $1.99
Previous CloseN/A
Volume3.16K
Average Volume (3M)2.71K
Market Cap
$8.72M
Enterprise Value$52.20M
Total Cash (Recent Filing)$866.46K
Total Debt (Recent Filing)$28.95M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Nov 18, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding12,692,942
10 Day Avg. Volume2,359
30 Day Avg. Volume2,712
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)-4.05
Price to Sales (P/S)10.37
P/FCF Ratio-2.32
Enterprise Value/Market Cap5.99
Enterprise Value/Revenue16.32
Enterprise Value/Gross Profit-5.49
Enterprise Value/Ebitda-5.64
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.41
Revenue Forecast (FY)$9.97M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRapid sequential and year-over-year revenue growth indicates improving commercial traction and expanding customer demand. If sustained, this growth can increase operating leverage, support capacity investment, and establish a stronger base for recurring revenue over the next several quarters.
Customer AdoptionRepeat purchases from 40 active customers provide evidence that Burcon’s ingredients are moving beyond evaluation into commercial use. This validation can support retention, broaden application adoption, and make future revenue growth more durable than one-time trial activity.
Scalable Product PortfolioCommercial production across sunflower, pea, fava and canola proteins demonstrates product breadth and progress in scaling Burcon’s technology across applications. A diversified portfolio may improve customer relevance and create more avenues for growth as plant-protein demand develops.
Bears Say
Severe UnprofitabilityExtremely negative gross, operating and net margins show that current revenue is not covering the cost of the business. Even with reported sales growth, the company must materially improve unit economics and operating efficiency before growth can translate into sustainable earnings.
Balance Sheet StressNegative equity combined with debt exceeding the asset base indicates a highly pressured capital structure and limited financial flexibility. This can constrain investment choices, increase dependence on financing, and leave the company more exposed if operating improvements take longer than expected.
Cash Burn And Financing DependencePersistent operating and free-cash-flow deficits mean Burcon is consuming cash while it scales, rather than funding expansion internally. Reliance on a sizeable convertible debenture raise increases execution and financing risk until the targeted transition to positive cash flow is achieved.
Burcon Nutrascience News
BRCNF FAQ
What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was $0.35 and its highest was $1.99 in the past 12 months.
What is Burcon Nutrascience’s market cap?
Burcon Nutrascience’s market cap is $8.72M.
When is Burcon Nutrascience’s upcoming earnings report date?
Burcon Nutrascience’s upcoming earnings report date is Nov 18, 2026 which is in 18 days.
How were Burcon Nutrascience’s earnings last quarter?
Burcon Nutrascience released its earnings results on Aug 12, 2026. The company reported -$0.215 earnings per share for the quarter, missing the consensus estimate of -$0.05 by -$0.165.
Is Burcon Nutrascience overvalued?
According to Wall Street analysts Burcon Nutrascience’s price is currently Overvalued.
Does Burcon Nutrascience pay dividends?
Burcon Nutrascience does not currently pay dividends.
What is Burcon Nutrascience’s EPS estimate?
Burcon Nutrascience’s EPS estimate is -0.12.
How many shares outstanding does Burcon Nutrascience have?
Burcon Nutrascience has 12,692,942 shares outstanding.
What happened to Burcon Nutrascience’s price movement after its last earnings report?
Burcon Nutrascience reported an EPS of -$0.215 in its last earnings report, missing expectations of -$0.05. Following the earnings report the stock price went down -0.746%.
Which hedge fund is a major shareholder of Burcon Nutrascience?
Currently, no hedge funds are holding shares in BRCNF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Burcon Nutrascience
Burcon NutraScience Corporation, along with its associated entities, is a Canadian enterprise specializing in the development and commercialization of plant-derived proteins and functional ingredients for the food and beverage sectors. Its extensive product line features Peazazz, a versatile pea protein suitable for a range of applications including dairy alternatives, ready-to-drink and dry-blended beverages, snack bars, baked goods, and meat substitutes. Also derived from peas, Peazac and Peazac 850 are tailored for plant-based meat alternatives, ready-to-mix powders and drinks, dairy-free options, and nutritional bars, particularly valued for their neutral taste profile and moderate textural properties. Among its canola-based proteins is Puratein, an isolate frequently utilized in meat alternatives such as burgers and sausages, as well as nutrition bars. Supertein, a pale-hued canola protein powder, is incorporated into non-dairy frozen desserts, egg replacers, plant-based marshmallows, ready-to-mix beverages, whipped toppings, and plant-based snack bars. Additionally, Nutratein, a canola protein composed of globulin and albumin, finds utility in meat and egg alternatives, alongside various other functional plant-based foods. Further expanding its offerings are Nutratein-PS and Nutratein-TZ, custom blends featuring its Peazac pea protein, alongside CLARISOY, a soy protein employed across sports nutrition beverages, citrus and fruit-flavored drinks, lemonades, powdered beverage mixes, and diverse other food and dietary items. Finally, MeritPro stands as a unique nutritional protein blend, distinguished by being allergen-free, gluten-free, dairy-free, non-GMO, and vegan-friendly. Originally incorporated in 1998 as Burcon Capital Corp., the firm rebranded to Burcon NutraScience Corporation in October 1999. Its corporate headquarters are situated in Vancouver, Canada.
BRCNF Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was constructive and execution-focused: management reported strong sequential and year-over-year revenue growth (54% QoQ; >3x YoY), growing customer adoption with 40 active buyers and repeat purchases, production scaling across multiple products, and put in place financing (up to $8.1M convertible debentures plus $3M undrawn tranche) to expand capacity and pursue near-term targets. Material risks remain — the company is still unprofitable, depends on additional funding and capacity expansions, and growth is back-end loaded and contingent on converting its sales funnel. On balance, the positives around commercial validation, production progress and committed financing outweigh the risks, although execution and timing remain key.View all BRCNF earnings summaries




